Open Journal of Gastroenterology
Vol.8 No.4(2018), Paper ID 84229, 7
pages
DOI:10.4236/ojgas.2018.84016
Early Serum Carcinoembryonic Antigen Reduction Predicts Tumor Shrinkage and Overall Survival in Colorectal Cancer Patients with Distant Metastasis, after Primary Surgery Followed by Mfolfox6 Plus Bevacizumab Treatment
Satoru Yamaguchi, Hideo Ogata, Daisuke Katsumata, Masanobu Nakajima, Kinro Sasaki, Hiroyuki Kato
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Department of Surgical Oncology, Dokkyo Medical University, Mibu, Japan
Copyright © 2018 Satoru Yamaguchi, Hideo Ogata, Daisuke Katsumata, Masanobu Nakajima, Kinro Sasaki, Hiroyuki Kato et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Yamaguchi, S. , Ogata, H. , Katsumata, D. , Nakajima, M. , Sasaki, K. and Kato, H. (2018) Early Serum Carcinoembryonic Antigen Reduction Predicts Tumor Shrinkage and Overall Survival in Colorectal Cancer Patients with Distant Metastasis, after Primary Surgery Followed by Mfolfox6 Plus Bevacizumab Treatment.
Open Journal of Gastroenterology,
8, 147-153. doi:
10.4236/ojgas.2018.84016.